Creeping fat-derived mechanosensitive fibroblasts drive intestinal fibrosis in Crohn's disease strictures
- PMID: 40967215
- PMCID: PMC12453597
- DOI: 10.1016/j.cell.2025.08.029
Creeping fat-derived mechanosensitive fibroblasts drive intestinal fibrosis in Crohn's disease strictures
Abstract
A significant complication of Crohn's disease (CD) is intestinal fibrosis, which narrows the bowel lumen to form a stricture. Creeping fat (CF) is the wrapping of mesenteric adipose tissue around diseased bowel, of which the role in CD stricture progression is unclear. By constructing a human single-cell CD fibroblast atlas, we identified CF-derived, CTHRC1+ fibroblasts enriched for Yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TAZ) signatures and localized to a fibrotic CF-bowel wall interface within the stricture. We further showed that analogous Cthrc1+ mouse fibroblasts derive from mesenteric adipose tissue stromal cells, infiltrate fibrotic bowel, and deposit extracellular matrix in a YAP/TAZ-dependent manner in a mouse model of intestinal fibrosis. Our findings identify CF as a key source of pro-fibrotic fibroblasts and raise the possibility of improving future clinical management of stricture progression by targeting not only the bowel but also CF.
Keywords: Crohn’s disease; Yes-associated protein; creeping fat; fibroblasts; fibrosis; inflammatory bowel disease; meta-analysis; scRNA-seq; strictures.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests S.L.N. is on the SAB of Seed Inc. and is a co-founder of Stara Biosciences. Stanford Provisional patent: “YAP Inhibition for Intestinal Fibrosis,” serial number 63/818,707 (M.T.L., J.S.H., A.K., B.P., N.E.L., and K.E.B.-R.).
References
Grants and funding
LinkOut - more resources
Full Text Sources